Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about NIVOLUMAB: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | NIVOLUMAB |
| Key Genes/Proteins | PD-1, PD-L1 |
| Related Diseases | CANCER, RENAL CELL CARCINOMA |
graph TD
NIVOLUMAB[NIVOLUMAB]
NIVOLUMAB -->|targets| PDCD1[PDCD1]
NIVOLUMAB -->|target for| PEMBROLIZUMAB[PEMBROLIZUMAB]
NIVOLUMAB -->|target for| PD_L1[PD-L1]
NIVOLUMAB -->|target for| PD_1[PD-1]| Target | Relation | Type | Str |
|---|---|---|---|
| PDCD1 | targets | protein | 0.90 |
| PEMBROLIZUMAB | associated_with | drug | 0.45 |
| RENAL CELL CARCINOMA | associated_with | disease | 0.45 |
| SUNITINIB | associated_with | drug | 0.45 |
| CANCER | associated_with | disease | 0.45 |
| PD-L1 | therapeutic_target | gene | 0.35 |
| PD-1 | therapeutic_target | gene | 0.35 |
| PEMBROLIZUMAB | therapeutic_target | drug | 0.35 |
| Source | Relation | Type | Str |
|---|---|---|---|
| PEMBROLIZUMAB | associated_with | drug | 0.45 |
| ATEZOLIZUMAB | associated_with | drug | 0.45 |
| RENAL CELL CARCINOMA | associated_with | disease | 0.45 |
| IPILIMUMAB | associated_with | drug | 0.45 |
| SUNITINIB | associated_with | drug | 0.45 |
| DURVALUMAB | associated_with | drug | 0.45 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning NIVOLUMAB in their description or question text
No additional research found